{"name": "JB Therapeutics",
 "permalink": "jb-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/jb-therapeutics",
 "homepage_url": "http://www.jbtherapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@jbtherapeutics.com",
 "phone_number": "1-617-413-3020",
 "description": "Biopharmaceutical Company ",
 "created_at": "Thu Apr 12 03:34:28 UTC 2012",
 "updated_at": "Thu Apr 12 03:46:25 UTC 2012",
 "overview": "\u003Cp\u003EJB Therapeutics is a clinical stage biopharmaceutical company developing the first new class of analgesic agents in two decades. Their lead compound, JBT-101, is a potent CB1 and CB2 agonist with demonstrated efficacy in several animal models of pain and inflammation. It has also completed a Phase II clinical study in chronic refractory neuropathic pain. JBT-101 is currently being developed as a potential disease modifying treatment for osteoarthritis. JBT-101 also represents a platform for combination with other anti-inflammatory and analgesic agents as well as various drug delivery strategies including ointment and gels, topical patches, and timed release formulations.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       33],
      "assets/images/resized/0018/3837/183837v1-max-150x150.jpg"],
     [[250,
       56],
      "assets/images/resized/0018/3837/183837v1-max-250x250.jpg"],
     [[311,
       70],
      "assets/images/resized/0018/3837/183837v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$662k",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.masshightech.com/stories/2012/04/09/daily34-JB-Therapeutics-raises-662K-to-start-scleroderma-trial.html",
    "source_description": "JB Therapeutics raises $662K to start scleroderma trial",
    "raised_amount": 662000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 4,
    "funded_day": 11,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "508 Dudley Road",
    "address2": "",
    "zip_code": "02459",
    "city": "Newton Center",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}